- Home
- EMF vs OM Comparison
EMF vs OM Comparison
Compare EMF & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMF
- OM
- Stock Information
- Founded
- EMF 1987
- OM 2003
- Country
- EMF United States
- OM United States
- Employees
- EMF N/A
- OM N/A
- Industry
- EMF Finance/Investors Services
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EMF Finance
- OM Health Care
- Exchange
- EMF Nasdaq
- OM Nasdaq
- Market Cap
- EMF 219.3M
- OM 247.1M
- IPO Year
- EMF N/A
- OM 2020
- Fundamental
- Price
- EMF $15.45
- OM $13.86
- Analyst Decision
- EMF
- OM Hold
- Analyst Count
- EMF 0
- OM 1
- Target Price
- EMF N/A
- OM $22.00
- AVG Volume (30 Days)
- EMF 29.3K
- OM 198.3K
- Earning Date
- EMF 01-01-0001
- OM 11-05-2025
- Dividend Yield
- EMF 6.16%
- OM N/A
- EPS Growth
- EMF N/A
- OM N/A
- EPS
- EMF N/A
- OM N/A
- Revenue
- EMF N/A
- OM $119,304,000.00
- Revenue This Year
- EMF N/A
- OM $12.37
- Revenue Next Year
- EMF N/A
- OM $10.52
- P/E Ratio
- EMF N/A
- OM N/A
- Revenue Growth
- EMF N/A
- OM 2.47
- 52 Week Low
- EMF $10.58
- OM $5.85
- 52 Week High
- EMF $12.67
- OM $25.35
- Technical
- Relative Strength Index (RSI)
- EMF 62.70
- OM 45.10
- Support Level
- EMF $15.08
- OM $13.01
- Resistance Level
- EMF $15.69
- OM $14.22
- Average True Range (ATR)
- EMF 0.27
- OM 0.58
- MACD
- EMF -0.02
- OM 0.20
- Stochastic Oscillator
- EMF 80.00
- OM 65.17
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.